Next Science Limited
NXSCF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | $16,362 | $20,368 | $49,590 | $54,688 |
| - Cash | $971 | $1,674 | $3,572 | $9,239 |
| + Debt | $5,302 | $2,493 | $825 | $962 |
| Enterprise Value | $20,692 | $21,188 | $46,843 | $46,412 |
| Revenue | $10,491 | $11,577 | $11,234 | $12,591 |
| % Growth | -9.4% | 3.1% | -10.8% | – |
| Gross Profit | $8,725 | $9,477 | $8,962 | $9,208 |
| % Margin | 83.2% | 81.9% | 79.8% | 73.1% |
| EBITDA | -$4,094 | -$4,123 | -$5,261 | -$6,984 |
| % Margin | -39% | -35.6% | -46.8% | -55.5% |
| Net Income | -$4,688 | -$4,743 | -$5,840 | -$7,990 |
| % Margin | -44.7% | -41% | -52% | -63.5% |
| EPS Diluted | -0.016 | -0.016 | -0.03 | -0.031 |
| % Growth | 1.2% | 46% | 2.3% | – |
| Operating Cash Flow | -$2,783 | -$2,926 | -$5,035 | -$7,833 |
| Capital Expenditures | $0 | -$35 | -$12 | -$405 |
| Free Cash Flow | -$2,783 | -$2,961 | -$5,047 | -$8,239 |